GSTT2
geneOn this page
Summary
GSTT2 (glutathione S-transferase theta 2 (gene/pseudogene), HGNC:4642) is a protein-coding gene on chromosome 22q11.23, encoding Glutathione S-transferase theta-2 (P0CG29). Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.
The protein encoded by this gene, glutathione S-transferase (GST) theta 2 (GSTT2), is a member of a superfamily of proteins that catalyze the conjugation of reduced glutathione to a variety of electrophilic and hydrophobic compounds. Human GSTs can be divided into five main classes: alpha, mu, pi, theta, and zeta. The theta class includes GSTT1, GSTT2, and GSTT2B. GSTT2 and GSTT2B are nearly identical to each other, and share 55% amino acid identity with GSTT1. All three genes may play a role in human carcinogenesis. The GSTT2 gene is a pseudogene in some populations.
Source: NCBI Gene 2953 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 18 total — 1 pathogenic, 1 likely-pathogenic
- Druggable target: yes
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4642 |
| Approved symbol | GSTT2 |
| Name | glutathione S-transferase theta 2 (gene/pseudogene) |
| Location | 22q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000099984 |
| Ensembl biotype | protein_coding |
| OMIM | 600437 |
| Entrez | 2953 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding_LoF
ENST00000402588, ENST00000634759
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000402588 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001709804 | 23982628 | 23982778 |
| ENSE00001730025 | 23980948 | 23981035 |
| ENSE00001938639 | 23980058 | 23980309 |
| ENSE00001946516 | 23983397 | 23983710 |
| ENSE00003787167 | 23982871 | 23983002 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 79.49.
FANTOM5 (CAGE): breadth broad, TPM avg 0.9431 / max 37.6472, expressed in 529 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 191349 | 0.9431 | 529 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.49 | gold quality |
| stromal cell of endometrium | CL:0002255 | 74.96 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 74.92 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 68.68 | gold quality |
| prefrontal cortex | UBERON:0000451 | 66.42 | gold quality |
| fundus of stomach | UBERON:0001160 | 65.60 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 65.54 | gold quality |
| apex of heart | UBERON:0002098 | 65.11 | gold quality |
| primary visual cortex | UBERON:0002436 | 64.65 | gold quality |
| colonic epithelium | UBERON:0000397 | 62.92 | silver quality |
| left adrenal gland | UBERON:0001234 | 62.73 | gold quality |
| frontal cortex | UBERON:0001870 | 62.73 | gold quality |
| ascending aorta | UBERON:0001496 | 62.70 | gold quality |
| right adrenal gland | UBERON:0001233 | 62.30 | gold quality |
| thoracic aorta | UBERON:0001515 | 62.28 | gold quality |
| right atrium auricular region | UBERON:0006631 | 62.28 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 61.84 | gold quality |
| left coronary artery | UBERON:0001626 | 61.78 | gold quality |
| tibial artery | UBERON:0007610 | 61.60 | gold quality |
| popliteal artery | UBERON:0002250 | 61.35 | gold quality |
| prostate gland | UBERON:0002367 | 61.06 | gold quality |
| cortex of kidney | UBERON:0001225 | 60.67 | gold quality |
| adrenal gland | UBERON:0002369 | 60.66 | gold quality |
| left ovary | UBERON:0002119 | 60.17 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 59.91 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 59.65 | gold quality |
| lower esophagus | UBERON:0013473 | 59.02 | gold quality |
| skin of leg | UBERON:0001511 | 58.99 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 58.78 | gold quality |
| zone of skin | UBERON:0000014 | 58.67 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.34 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): AR
Literature-anchored findings (GeneRIF, showing 8)
- dinitrosyl-diglutathionyl-iron complex, a natural carrier of nitric oxide, binds with extraordinary affinity to GSTA1-1, which is explained by molecular modeling and related to molecular evolution (PMID:12871945)
- single nucleotide polymorphisms and haplotypes of the GSTT2 promoter region are associated with colorectal cancer risk in the Korean population (PMID:17250773)
- PAH-DNA adduct formation could be modulated by common genetic variants in GSTT2 in African American, Dominican and Caucasian mothers and newborns. (PMID:18268125)
- GSTM1 (1p13.3) and GSTT2 (22q11.23) showed a statistically significant association of non-null genotypes at both loci with an additive effect for increased vulnerability to schizophrenia (PMID:19528963)
- analysis of glutathione S-transferase copy number variation alters lung gene expression (PMID:21349909)
- Polyphenol metabolites did not affect cell number but significantly upregulated GSTT2 expression and decreased COX-2. (PMID:21598179)
- Increased levels of GSTT2 in esophageal tissues of African American individuals might protect them from GERD-induced damage and contribute to the low incidence of esophageal adenocarcinoma in this population. (PMID:30578782)
- Proanthocyanidins mitigate bile acid-induced changes in GSTT2 levels in a panel of racially diverse patient-derived primary esophageal cell cultures. (PMID:34758158)
Cross-species orthologs
42 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gstr | ENSDARG00000042620 |
| danio_rerio | gstt2 | ENSDARG00000095464 |
| mus_musculus | Gstt2 | ENSMUSG00000033318 |
| rattus_norvegicus | Gstt2 | ENSRNOG00000052415 |
| drosophila_melanogaster | GstD1 | FBGN0001149 |
| drosophila_melanogaster | GstD2 | FBGN0010038 |
| drosophila_melanogaster | GstD3 | FBGN0010039 |
| drosophila_melanogaster | GstD4 | FBGN0010040 |
| drosophila_melanogaster | GstD5 | FBGN0010041 |
| drosophila_melanogaster | GstD6 | FBGN0010042 |
| drosophila_melanogaster | GstD7 | FBGN0010043 |
| drosophila_melanogaster | GstD8 | FBGN0010044 |
| drosophila_melanogaster | GstE12 | FBGN0027590 |
| drosophila_melanogaster | Clic | FBGN0030529 |
| drosophila_melanogaster | GstT3 | FBGN0031117 |
| drosophila_melanogaster | GstE13 | FBGN0033381 |
| drosophila_melanogaster | GstE1 | FBGN0034335 |
| drosophila_melanogaster | GstE11 | FBGN0034354 |
| drosophila_melanogaster | GstO3 | FBGN0035904 |
| drosophila_melanogaster | GstO2 | FBGN0035906 |
| drosophila_melanogaster | GstO1 | FBGN0035907 |
| drosophila_melanogaster | GstD9 | FBGN0038020 |
| drosophila_melanogaster | GstD10 | FBGN0042206 |
| drosophila_melanogaster | GstT1 | FBGN0050000 |
| drosophila_melanogaster | GstT2 | FBGN0050005 |
| drosophila_melanogaster | GstE9 | FBGN0063491 |
| drosophila_melanogaster | GstE8 | FBGN0063492 |
| drosophila_melanogaster | GstE7 | FBGN0063493 |
| drosophila_melanogaster | GstE6 | FBGN0063494 |
| drosophila_melanogaster | GstE5 | FBGN0063495 |
| drosophila_melanogaster | GstE4 | FBGN0063496 |
| drosophila_melanogaster | GstE3 | FBGN0063497 |
| drosophila_melanogaster | GstE2 | FBGN0063498 |
| drosophila_melanogaster | GstE10 | FBGN0063499 |
| drosophila_melanogaster | se | FBGN0086348 |
| caenorhabditis_elegans | exc-4 | WBGENE00001365 |
| caenorhabditis_elegans | WBGENE00001371 | |
| caenorhabditis_elegans | gst-43 | WBGENE00001791 |
| caenorhabditis_elegans | WBGENE00001792 | |
| caenorhabditis_elegans | WBGENE00015337 | |
| caenorhabditis_elegans | WBGENE00021817 | |
| caenorhabditis_elegans | WBGENE00043097 |
Paralogs (14): GSTO2 (ENSG00000065621), GSTZ1 (ENSG00000100577), GDAP1 (ENSG00000104381), CLIC5 (ENSG00000112782), GDAP1L1 (ENSG00000124194), GSTT2B (ENSG00000133433), GSTO1 (ENSG00000148834), CLIC2 (ENSG00000155962), CLIC6 (ENSG00000159212), CLIC4 (ENSG00000169504), CLIC3 (ENSG00000169583), CLIC1 (ENSG00000213719), EEF1G (ENSG00000254772), GSTT4 (ENSG00000276950)
Protein
Protein identifiers
Glutathione S-transferase theta-2 — P0CG29 (reviewed: P0CG29)
Alternative names: GST class-theta-2
All UniProt accessions (0):
UniProt curated annotations — full annotation on UniProt →
Function. Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Has a sulfatase activity.
Subunit / interactions. Homodimer.
Subcellular location. Cytoplasm. Cytosol. Nucleus.
Tissue specificity. Expressed at low levels in liver. In lung, expressed at low levels in ciliated bronchiolar cells, alveolar macrophages and alveolar type II cells.
Similarity. Belongs to the GST superfamily. Theta family.
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004045 | Glutathione_S-Trfase_N | Domain |
| IPR004046 | GST_C | Domain |
| IPR010987 | Glutathione-S-Trfase_C-like | Domain |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
| IPR036282 | Glutathione-S-Trfase_C_sf | Homologous_superfamily |
| IPR040075 | GST_N_Theta | Domain |
| IPR040077 | GST_C_Theta | Domain |
| IPR040079 | Glutathione_S-Trfase | Family |
| IPR051369 | GST_Theta | Family |
Pfam: PF00043, PF02798
Catalyzed reactions (Rhea), 1 shown:
- RX + glutathione = an S-substituted glutathione + a halide anion + H(+) (RHEA:16437)
UniProt features (34 total): helix 14, strand 6, turn 5, binding site 4, domain 2, initiator methionine 1, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 4MPF | X-RAY DIFFRACTION | 2.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0CG29-F1 | 97.70 | 0.99 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 40–41; 53–54; 66–67; 104–107
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-156590 | Glutathione conjugation |
MSigDB gene sets: 154 (showing top):
REACTOME_BIOLOGICAL_OXIDATIONS, BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, DACOSTA_UV_RESPONSE_VIA_ERCC3_UP, CHANDRAN_METASTASIS_DN, GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY, BLALOCK_ALZHEIMERS_DISEASE_UP, GOBP_AMIDE_METABOLIC_PROCESS, BROWNE_HCMV_INFECTION_14HR_DN, CAIRO_HEPATOBLASTOMA_DN, MORI_PRE_BI_LYMPHOCYTE_UP, WELCH_GATA1_TARGETS, REACTOME_GLUTATHIONE_CONJUGATION, GOBP_GLUTATHIONE_METABOLIC_PROCESS, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0, CUI_TCF21_TARGETS_2_UP
GO Biological Process (1): glutathione metabolic process (GO:0006749)
GO Molecular Function (1): glutathione transferase activity (GO:0004364)
GO Cellular Component (4): nucleus (GO:0005634), cytoplasm (GO:0005737), cytosol (GO:0005829), extracellular exosome (GO:0070062)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Phase II - Conjugation of compounds | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| modified amino acid metabolic process | 1 |
| sulfur compound metabolic process | 1 |
| transferase activity, transferring alkyl or aryl (other than methyl) groups | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GSTT2 | MOCS2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CFTR | GSTT2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| THEM4 | KIAA0391 | psi-mi:“MI:0914”(association) | 0.350 |
| THEM4 | PRORP | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A1W2PR19, A6QQZ0, O09131, O65857, O76483, O88741, P09488, P0CG29, P0CG30, P21266, P28161, P28342, P30109, P30568, P30713, P42760, P46409, P46430, P46439, P46440, P48774, P57108, P78417, Q01579, Q03013, Q03425, Q03662, Q4V8E6, Q5BK56, Q5R8E8, Q61133, Q64471, Q84TK0, Q8R5I6, Q8TB36, Q9BEA9, Q9BEB0, Q9C6C8, Q9D4P7, Q9FE46
Diamond homologs: A0A1U8QXK4, A0A6J4B5J2, A2Q127, C8VQ63, P0CG29, P0CG30, P12261, P26641, P26642, P29547, P29694, P36008, P40921, P42936, Q00717, Q29387, Q3SZV3, Q4R7H5, Q4WB03, Q5Z627, Q68FR6, Q6PE25, Q6YW46, Q90YC0, Q9D8N0, Q9FUM1, Q9VG98, Q9ZRI7, S0EHD0, W7MMJ0, A0A1W2PR19, O76483, O77473, P20135, P30711, P30713, P46430, P57108, Q01579, Q03425
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
18 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 1 |
| Uncertain significance | 10 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2684933 | GRCh37/hg19 22q11.23(chr22:23690388-25066472)x3 | Pathogenic |
| 3064991 | NM_000854.1(GSTT2):c.200+1G>A | Likely pathogenic |
SpliceAI
995 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:23980304:TCA:T | donor_gain | 1.0000 |
| 22:23980305:CAAAG:C | donor_loss | 1.0000 |
| 22:23980307:AAG:A | donor_loss | 1.0000 |
| 22:23980308:AGGT:A | donor_loss | 1.0000 |
| 22:23980309:GGTG:G | donor_loss | 1.0000 |
| 22:23980310:GT:G | donor_loss | 1.0000 |
| 22:23980311:T:G | donor_loss | 1.0000 |
| 22:23980944:TCAG:T | acceptor_loss | 1.0000 |
| 22:23980946:A:AC | acceptor_loss | 1.0000 |
| 22:23980946:A:AG | acceptor_gain | 1.0000 |
| 22:23980946:AG:A | acceptor_gain | 1.0000 |
| 22:23980947:G:GA | acceptor_gain | 1.0000 |
| 22:23980947:GG:G | acceptor_gain | 1.0000 |
| 22:23980947:GGGC:G | acceptor_gain | 1.0000 |
| 22:23980947:GGGCA:G | acceptor_gain | 1.0000 |
| 22:23981010:G:GT | donor_gain | 1.0000 |
| 22:23981011:A:T | donor_gain | 1.0000 |
| 22:23982456:G:GT | donor_gain | 1.0000 |
| 22:23982624:CCAGC:C | acceptor_loss | 1.0000 |
| 22:23982626:A:AG | acceptor_gain | 1.0000 |
| 22:23982626:AGCT:A | acceptor_loss | 1.0000 |
| 22:23982626:AGCTC:A | acceptor_gain | 1.0000 |
| 22:23982627:G:GT | acceptor_gain | 1.0000 |
| 22:23982627:GC:G | acceptor_gain | 1.0000 |
| 22:23982627:GCT:G | acceptor_gain | 1.0000 |
| 22:23982627:GCTC:G | acceptor_gain | 1.0000 |
| 22:23982627:GCTCG:G | acceptor_gain | 1.0000 |
| 22:23982774:TCCAG:T | donor_loss | 1.0000 |
| 22:23982777:AG:A | donor_loss | 1.0000 |
| 22:23982778:GG:G | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000959418 (22:23982069 C>G), RS1004081892 (22:23984174 A>G), RS1004855495 (22:23980808 G>T), RS1007882230 (22:23982230 T>G), RS1012870914 (22:23980857 G>A,C), RS1019225265 (22:23982248 G>C), RS1023798660 (22:23980871 G>A,C), RS1027286812 (22:23982288 C>T), RS1039535364 (22:23980699 A>T), RS1041168496 (22:23984074 C>T), RS1045665383 (22:23981985 A>C), RS1052550288 (22:23983434 C>T), RS1056474739 (22:23981233 T>C,G), RS1056738118 (22:23980821 T>A), RS1126752 (22:23982630 C>T)
Disease associations
OMIM: gene MIM:600437 | disease phenotypes: MIM:604004
GenCC curated gene-disease
Mondo (1): megalencephalic leukoencephalopathy with subcortical cysts 1 (MONDO:0024555)
Orphanet (1): Megalencephalic leukoencephalopathy with subcortical cysts (Orphanet:2478)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003483_1 | S-phenylmercapturic acid levels in smokers | 3.000000e-134 |
| GCST003483_2 | S-phenylmercapturic acid levels in smokers | 2.000000e-46 |
| GCST010244_364 | Triglyceride levels | 4.000000e-11 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007651 | urinary S-phenylmercapturic acid measurement |
| EFO:0004530 | triglyceride measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL2142 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| apple polyphenol extract | increases expression | 2 |
| Butyrates | decreases expression, increases expression | 2 |
| Valproic Acid | affects cotreatment, increases expression, increases methylation | 2 |
| Aflatoxin B1 | increases expression, increases methylation | 2 |
| bis(tri-n-butyltin)oxide | increases expression | 1 |
| 1-menaphthyl sulfate | affects metabolic processing | 1 |
| 2-hydroxychavicol | increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Bosentan | decreases expression | 1 |
| Artesunate | affects response to substance | 1 |
| Acetaminophen | increases expression | 1 |
| Acetylglucosamine | increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Etoposide | affects response to substance | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Paraoxon | increases expression | 1 |
| Parathion | increases expression | 1 |
| Plant Extracts | increases expression | 1 |
| Sarin | decreases expression | 1 |
| Mifepristone | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 admet
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL1743236 | ADMET | Substrates for human cytosolic glutathione transferase GSTT2 | Casarett and Doull’s Toxicology The Basic Science of Poisons, 7th edition |
Clinical trials (associated diseases)
2 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT02699190 | Not specified | COMPLETED | LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies |
| NCT03047369 | Not specified | RECRUITING | The Myelin Disorders Biorepository Project |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): megalencephalic leukoencephalopathy with subcortical cysts 1